SAN DIEGO, June 9 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has established a distribution partnership for the Italian market through Medimar Italia, a Milan-based firm specializing in medical device sales in the country.
Michel Vaudry, SpectraScience's Director of International Sales commented that, "We are pleased to have added our second European distributor in the past two months. Medimar is a respected and well-established medical device distributor and its decision to add the WavSTAT Optical Biopsy System to their portfolio is a strong validation of our technology."
Medimar's President, Francesco Torelli, stated that, "SpectraScience's WavSTAT cancer diagnosis system has tremendous potential to impact the marketplace here in Italy. The importance of earlier and more effective screening for colon cancer cannot be stressed enough and we look forward to representing the product and working with SpectraScience to establish and build a strong Italian market presence."
Vaudry added that, "Mr. Torelli is a respected thought leader in the
medical device market in Italy, so his support of the WavSTAT System will
be instrumental in our acceptance into the major gastroenterology centers
in the country."
Key Benefits to the WavSTAT Optical Biopsy System
-- Helps the physician discern between normal and pre-cancerous tissue in
the GI tract
-- Gives the physician additional information that allows for a more
informed decision on leaving polyps on site if they are not
pre-cancerous thereby minimizing risks and time.
-- Provides the opportunity for physicians to perform a physical biopsy at
exactly the same site and time that the optical biopsy is performed
-- Allows physicians to determine the margin, or border of the
-- Aids physicians during
|SOURCE SpectraScience, Inc.|
Copyright©2008 PR Newswire.
All rights reserved